ARCHIVES

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

This article is from The Cancer Letter archive.

Vol. 26 No. 5 | May 30, 2003

Download PDF Visit The Full Archive

Related Articles

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000

FDA News: Rep. Barton Expresses “Concern” About Plan To Merge Offices

May 22, 1998

Advisors Clear Herceptin; Find Tamoxifen Indicated For “Short Term Risk Reduction”

September 11, 1998

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

Evidence “Weak” Linking EMFs, cancer

June 25, 1999

Bush Limits Drug Company Efforts To Block Generics

October 25, 2002